Psilocybin as a disease-modifying drug—a salutogenic approach in psychiatry
Deutsches Ärzteblatt international December 16, 2024 Moritz Spangemacher, Andrea Jungaberle, Henrik Jungaberle et al. 3 citations
Treatment with psilocybin differs fundamentally from classic psychopharmacotherapy. Its potentially transdiagnostic, rapid, and sustainable efficacy and its positive effect on further dimensions of mental health beyond the patient's symptoms and psychopathology imply that it may have diseasemodifying and salutogenic mechanisms of action. Psychotherapy accompanied by the administration of...